Global Access Kerafast provides a worldwide platform for researchers to access unique laboratory-made reagents, presenting an opportunity to expand distribution partnerships and reach international academic and nonprofit labs that value hard-to-find tools.

Royalty Model The business handles selling and shipping while returning royalties to providing labs, creating a compelling case to partner laboratories for revenue-sharing collaborations and incentivizing broader supplier participation.

Antibody Focus As part of Absolute Biotech with a strong emphasis on antibody reagents and services, there is a clear cross-sell opportunity to Up-sell antibodies, recombinant technologies, and related services to Kerafast’s existing customer base.

Strategic Partnerships Past acquisitions and mergers with Absolute Antibody and subsequent integration into Absolute Biotech indicate openness to strategic collaborations, joint marketing, and co-branded campaigns with suppliers and research institutions.

Emerging Lab Tools Expansion into products like patient-derived xenograft models and viral pseudotyping systems suggests opportunities to bundle niche research tools with complementary reagents, enabling bundled offerings to targeted labs focused on cutting-edge biology.